| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |